Colorectal Cancer

Despite all the dangers involved with colorectal cancer, many people do not keep up to date with recommended colonoscopy screening. About one-third of individuals are behind. With so many barriers and difficulties in place, researchers are left to find ways to make getting patients to colonoscopy easier.

For patients with inflammatory bowel disease who were undergoing surveillance for colorectal neoplasia, indefinite dysplasia was associated with an increased risk for the development of advanced colorectal neoplasia, according to study results.

Healio Gastroenterology and Liver Disease has compiled a list of some of the top stories we reported in August.

Results of a meta-analysis revealed that using a fecal immunochemical test positivity threshold of 10 µg hemoglobin/g feces or less, rather than between 10 and 20 µg hemoglobin/g feces, can increase the sensitivity for detecting colorectal cancers by more than 10%.

Incidence of interval colorectal cancer after a negative result from a fecal immunochemical test is low, according to data collected from a population-based screening program.

Patients with metastatic colorectal cancer who exercised regularly achieved longer PFS than those who did not, according to results of a companion study to the Cancer and Leukemia Group B/SWOG 80305 trial published in Journal of Clinical Oncology.

Certain oral antibiotics are associated with increased risk for colon cancer, while others are linked with reduced rectal cancer risk, according to study results published in Gut.

Multiple rounds of fecal immunochemical tests sent to patients through the mail had a higher diagnostic yield for advanced neoplasia among invitees compared with one-time flexible sigmoidoscopy or one-time colonoscopy, according to study results.

A low-cost, literacy-appropriate intervention with follow-up phone calls if needed increased colorectal cancer screening among an underserved, rural population in Louisiana, according to results of a two-arm randomized trial published in Cancer.

LOS ANGELES — In this exclusive video from GI Outlook 2019, T.R. Levin, MD, the chief of gastroenterology at Kaiser Permanente Medical Center, discusses the future of colorectal cancer screening and its viability in practice management.